The weight-loss drug market just got more complicated. Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from the platform after accusing the company of selling “illegitimate, knockoff versions” that could put patients at risk, according to CBS News. This breakup matters for anyone considering these increasingly popular…
Read the full article here
